Natalie M Brousseau
Biographic Data
| ID | 7843164 |
|---|---|
| NAME | Natalie M Brousseau |
| GIVEN NAMES | Natalie M |
| FAMILY NAME | Brousseau |
| SIGNATURE | BROUSSEAU N M |
| AFFILIATIONS | University of Connecticut |
| ORCID | 0000-0003-4450-8888 |
| VERIFIED | Yes |
| TOTAL WORKS | 4 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 4 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2018 |
| LATEST PUBLICATION YEAR | 2024 |
| H-INDEX | 0 |
Enacted stigma from family and drug use during opioid use disorder treatment
Enacted stigma (i.e., experiences of discrimination from others) is associated with engagement in drug use among people with a wide range of stigmatized statuses. This association may be particularly concerning among people receiving treatment for opioid use disorder (OUD), among whom continued drug use may undermine treatment outcomes and increase risk of overdose. Although past research largely overlooks the source of enacted stigma, theory and…
Amphetamine use and its associations with antiretroviral adherence and viral load among sexual minority men and transgender women living with HIV
Substance use has complex associations to HIV disease progression. The current study tested the associations between several substances and HIV viral load while accounting for confounders relevant to HIV disease progression and substance use. Young sexual minority men and transgender women living with HIV (LWH) in Georgia (N = 385) completed measures and biological tests for HIV viral load and substance use. Multivariable regression models tested…
Anticipated stigma, stereotypes, and Covid-19 testing
Testing for COVID-19 is important for identifying, tracing, and treating COVID-19 cases as well as informing policy decisions Evidence from other disease epidemics suggests that anticipated stigma and stereotypes are barriers to testing for disease Anticipated stigma may undermine testing due to labeling avoidance (i e , efforts to avoid receiving the label of a stigmatized status) and stereotypes may undermine testing by reducing perceived vulne…
Disclosure, Stigma, and Social Support Among Young People Receiving Treatment for Substance Use Disorders and Their Caregivers
No prominent works on this page.
Disclosure, Stigma, and Social Support Among Young People Receiving Treatment for Substance Use Disorders and Their Caregivers
Anticipated stigma, stereotypes, and Covid-19 testing
Testing for COVID-19 is important for identifying, tracing, and treating COVID-19 cases as well as informing policy decisions Evidence from other disease epidemics suggests that anticipated stigma and stereotypes are barriers to testing for disease Anticipated stigma may undermine testing due to labeling avoidance (i e , efforts to avoid receiving the label of a stigmatized status) and stereotypes may undermine testing by reducing perceived vulne…
Amphetamine use and its associations with antiretroviral adherence and viral load among sexual minority men and transgender women living with HIV
Substance use has complex associations to HIV disease progression. The current study tested the associations between several substances and HIV viral load while accounting for confounders relevant to HIV disease progression and substance use. Young sexual minority men and transgender women living with HIV (LWH) in Georgia (N = 385) completed measures and biological tests for HIV viral load and substance use. Multivariable regression models tested…
Enacted stigma from family and drug use during opioid use disorder treatment
Enacted stigma (i.e., experiences of discrimination from others) is associated with engagement in drug use among people with a wide range of stigmatized statuses. This association may be particularly concerning among people receiving treatment for opioid use disorder (OUD), among whom continued drug use may undermine treatment outcomes and increase risk of overdose. Although past research largely overlooks the source of enacted stigma, theory and…
Medicine (4 works) · Psychiatry (4 works) · Psychology (4 works) · Clinical Psychology (3 works) · Clinical Psychology (2 works) · Internal Medicine (2 works) · Mental Health Treatment and Access (2 works) · Psychotherapist (2 works) · Stigma (botany (2 works) · Substance use (2 works)